1. Agdeppa, E.D., Kepe, V., Liu, J., Flores-Torres, S., Satyamurthy, N., Petric, A., Cole, G.M., Small, G.W., Huang, S.C. & Barrio, J.R. (2001) Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J. Neurosci., 21, RC189.
2. A National Alzheimer's Strategic Plan: The Report of the Alzheimer's Study Group, 2009.
3. Cerebrospinal Fluid Tau Protein as a Potential Diagnostic Marker in Alzheimer’s Disease
4. Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques.
5. Arai, H., Nakagawa, T., Kosaka, Y., Higuchi, M., Matsui, T., Okamura, N., Tashiro, M. & Sasaki, H. (1997) Elevated cerebrospinal fluid tau protein level as a predictor of dementia in memory-impaired individuals. Alzheim. Res., 3, 211-213.